Bryn Mawr Trust Advisors LLC Has $2.29 Million Holdings in Zoetis Inc. $ZTS

Bryn Mawr Trust Advisors LLC lifted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 12.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 14,669 shares of the company’s stock after acquiring an additional 1,628 shares during the quarter. Bryn Mawr Trust Advisors LLC’s holdings in Zoetis were worth $2,288,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in ZTS. Lindbrook Capital LLC grew its holdings in Zoetis by 1.8% during the first quarter. Lindbrook Capital LLC now owns 3,715 shares of the company’s stock valued at $612,000 after purchasing an additional 65 shares during the last quarter. Scott & Selber Inc. boosted its holdings in shares of Zoetis by 0.6% during the 2nd quarter. Scott & Selber Inc. now owns 11,652 shares of the company’s stock worth $1,817,000 after buying an additional 67 shares during the period. Secure Asset Management LLC boosted its holdings in shares of Zoetis by 2.9% during the 2nd quarter. Secure Asset Management LLC now owns 2,448 shares of the company’s stock worth $382,000 after buying an additional 68 shares during the period. Moment Partners LLC grew its stake in Zoetis by 3.2% in the 2nd quarter. Moment Partners LLC now owns 2,354 shares of the company’s stock valued at $367,000 after buying an additional 72 shares during the last quarter. Finally, CVA Family Office LLC raised its holdings in Zoetis by 6.7% in the 2nd quarter. CVA Family Office LLC now owns 1,173 shares of the company’s stock worth $183,000 after acquiring an additional 74 shares during the period. 92.80% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on ZTS shares. Leerink Partners cut shares of Zoetis from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $180.00 to $155.00 in a report on Thursday, July 17th. Stifel Nicolaus set a $140.00 price objective on Zoetis in a research report on Tuesday. UBS Group lowered their target price on Zoetis from $158.00 to $141.00 and set a “neutral” rating on the stock in a report on Wednesday. Leerink Partnrs downgraded Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Zoetis in a research report on Wednesday, October 8th. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $191.00.

Zoetis Trading Up 0.5%

Shares of ZTS opened at $120.20 on Friday. Zoetis Inc. has a 12-month low of $117.26 and a 12-month high of $181.85. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 1.05. The firm has a market capitalization of $53.27 billion, a price-to-earnings ratio of 20.69, a P/E/G ratio of 2.31 and a beta of 0.90. The stock’s 50-day moving average price is $144.21 and its 200 day moving average price is $152.60.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. The company had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.42 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The company’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter last year, the company earned $1.58 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, research analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be paid a dividend of $0.50 per share. The ex-dividend date is Friday, October 31st. This represents a $2.00 dividend on an annualized basis and a yield of 1.7%. Zoetis’s payout ratio is currently 33.67%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.